Physician profile
Gerardo Guadarrama
NPI 1215771043
$4,563.96
in general payments reported to CMS, 2019-2025
6 companies · $4,418 in 2025
The $4,418 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $146 · 2025: $4,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,160 · Food and Beverage: $1,396 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,160.24 |
| Food and Beverage | $1,396.29 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,467.56 | 2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,676.00 | 2025 | Acuvue |
| Bausch & Lomb Americas INC. | $287.48 | 2024-2025 | Infuse, Xiidra, Miebo |
| Harrow Eye, LLC | $75.72 | 2025 | Vevye |
| Alcon Vision LLC | $36.32 | 2025 | Tryptyr |
| Sun Pharmaceutical Industries INC. | $20.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerardo Guadarrama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.